ClinConnect ClinConnect Logo
Search / Trial NCT02958644

Effect of Synbiotic Supplement on the Body Mass Index of Participants With Severe Obesity

Launched by HOSPITAL DONA HELENA · Nov 7, 2016

Trial Information

Current as of June 29, 2025

Unknown status

Keywords

Synbiotic Obesity Body Mass Index Microbiota

ClinConnect Summary

Obesity has been discussed as one of the major diseases that require scientific and technological innovations for its control is obesity and studies indicate that microbiota of obese patients have a high level of intestinal microflora imbalance, with serious consequences such as loss of digestive function and the combination of toxins to protein.

Potential mediators of intestinal microbiota are prebiotics, probiotics and synbiotics, supplements considered safe because they are naturally contained in food and human microbiota. Its use has been studied as a new therapeutic approach for the r...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Obesity class III (body mass index ≥40kg/m2)
  • Exclusion Criteria:
  • Current use of prebiotics and probiotics or use in the last three months
  • Intolerance to prebiotics and probiotics

About Hospital Dona Helena

Hospital Dona Helena is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. With a commitment to excellence, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous clinical trials across various therapeutic areas. By fostering collaboration among healthcare professionals, researchers, and participants, Hospital Dona Helena aims to contribute to the development of novel therapies and enhance the quality of care within the community and beyond.

Locations

Joinville, Santa Catarina, Brazil

Joinville, Sc, Brazil

São Paulo, Sp, Brazil

Patients applied

0 patients applied

Trial Officials

Marilyn G Ferreira, PhD

Study Chair

Hospital Dona Helena

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials